Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Upgrades Teladoc Health to Neutral

Guggenheim Upgrades Teladoc Health to Neutral

Guggenheim analyst Sandy Draper upgrades Teladoc Health (NYSE:TDOC) from Sell to Neutral.

October 24, 2022

1 minute read

Guggenheim analyst Sandy Draper upgrades Teladoc Health (NYSE:TDOC) from Sell to Neutral.

PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing

August 31, 8:32 AM

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q2 2022 revenue was CA$2.1 million, a 375% increase compared to CA$446,000 in Q2 2021.

August 21, 9:00 AM

Baxter Intl (NYSE:BAX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

August 4, 10:21 AM

Morgan Stanley analyst Joseph Moore maintains Qorvo (NASDAQ:QRVO) with a Equal-Weight and lowers the price target from $120 to $109.

January 3, 1:00 PM

Barrington Research has decided to maintain its Outperform rating of US Physical Therapy (NYSE:USPH) and raise its price…